Cyber Monday Deal: Up to 60% off InvestingProCLAIM SALE

Bayer to invest 5 billion euros in weedkiller research

Published 06/14/2019, 03:55 AM
© Reuters. FILE PHOTO: Logo of Bayer AG is pictured at the annual results news conference of the German drugmaker in Leverkusen
BAYGN
-
MON
-

FRANKFURT (Reuters) - Bayer (DE:BAYGN), the German crop science and chemicals group reeling from U.S. litigation over claims its glyphosate pesticide causes cancer, said on Friday it would invest 5 billion euros ($5.64 billion) in weedkiller research.

Launching a public relations offensive to repair an image tarnished by fallout from its takeover of glyphosate maker Monsanto (NYSE:MON), Bayer also promised to reduce its environmental impact by 30% through 2030.

"We listened. We learned," Bayer said on its website https://www.bayer.com/en/our-commitments-on-transparency-sustainability-and-engagement.aspx, affirming its "heightened responsibility and ... unique potential to advance farming for the benefit of society and the planet."

Bayer shares recently plumbed seven-year lows after a California couple was last month awarded more than $2 billion, in the largest-ever U.S. jury award over claims that Monsanto's glyphosate-based weedkiller Roundup causes cancer.

It was the third consecutive U.S. jury verdict against Roundup, which Bayer acquired as part of its $63 billion purchase of Monsanto last year. Bayer says glyphosate is safe.

The share-price slide has left Bayer with a market valuation of $56 billion - less than it paid for Monsanto - piling pressure on CEO Werner Baumann who championed the takeover and has faced a backlash from shareholders.

Baumann has beefed up Bayer's crisis PR operation and taken personal charge of efforts to repair the company's image, as it also faces a backlash at home in Germany over a collapse in insect populations that environmentalists blame on excessive use of weedkillers by farmers.

"While glyphosate will continue to play an important role in agriculture and in Bayer’s portfolio, the company is committed to offering more choices for growers," Bayer said in a statement.

The company also said it would seek to reduce its environmental footprint by scaling down crop protection volumes and enabling more precise application. It would increase transparency around research efforts and the forthcoming process of re-registering glyphosate in the European Union.

"This will help to restore and retain biodiversity, combat climate change, and make the most efficient use of natural resources," it said.

© Reuters. FILE PHOTO: Logo of Bayer AG is pictured at the annual results news conference of the German drugmaker in Leverkusen

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.